Ohyama Masato, Ikeda Hiroyoshi, Yamaguchi Kazushige, Okabe Michio, Morimoto Yoshinori, Kawamoto Kazuyuki, Sano Kaoru, Paku Tebun, Imai Shiro, Yoshida Yasuo, Ito Tadashi, Ogasahara Keizo
Dept. of Surgery, Kurashiki Central Hospital.
Gan To Kagaku Ryoho. 2010 Feb;37(2):299-302.
We report a 37-year-old woman who complained of chest discomfort as of August 2004, and was found to have advanced esophageal cancer in the upper thoracic area in December 2004.S he was diagnosed as Stage IVa (T4N1M0) because chest computed tomography (CT) indicated trachea invasion and lymph node metastasis. We diagnosed it to be a case of unresectable esophageal cancer, and she underwent chemoradiation therapy. CT showed regression of the main tumor and metastatic lymph nodes when the CRT course was completed. The main tumor disappeared macroscopically. We again considered an operation, but the CRT was so effective that the patient wished to continue CRT and underwent three courses. Endoscopy showed disappearance of the main tumor and Lugol's solution. Following this, 10 courses of the treatment with CDDP alone (CDDP 10 mg/weekly) were continued until the appearance of renal dysfunction. S-1 (100 mg/body/day)was started in September 2005. The treatment is currently ongoing, and no recurrence or metastases had occurred as of March 2009.
我们报告一名37岁女性,自2004年8月起出现胸部不适,2004年12月被发现上胸段患有进展期食管癌。由于胸部计算机断层扫描(CT)显示气管侵犯和淋巴结转移,她被诊断为IVa期(T4N1M0)。我们诊断这是一例不可切除的食管癌,她接受了放化疗。完成放化疗疗程时,CT显示主肿瘤和转移性淋巴结缩小。主肿瘤肉眼可见消失。我们再次考虑手术,但放化疗效果非常好,患者希望继续放化疗并接受了三个疗程。内镜检查显示主肿瘤和卢戈氏碘液染色均消失。此后,单独使用顺铂(顺铂10mg/周)进行了10个疗程的治疗,直至出现肾功能障碍。2005年9月开始使用S-1(100mg/体/天)。目前治疗仍在进行中,截至2009年3月未发生复发或转移。